Turn It Down
Turbocharged Namenda Can Repair Alzheimer's Synapses
By Anette Breindl
Wednesday, June 19, 2013
By combining Namenda (memantine, Forest Laboratories Inc.) with nitroglycerin, researchers have developed a compound that appears capable of repairing damaged synapses in animal models of Alzheimer's disease. Such reversal of synaptic fortune might mean that the new compound, named Nitromemantine by its makers, could be developed into the first disease-modifying treatment for Alzheimer's.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.